Neuropeptide Y protects retinal neural cells against cell death induced by ecstasy

Neuroscience

Volumn 152, Issue 1, 2008, Pages 97-105

  Alvaro A R ^a   Martins, J ^a   Costa, A C ^a   Fernandes, E ^b   Carvalho, F ^b   Ambrosio A F ^a,c   Cavadas, C ^a,d  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b Faculty of Pharmacy   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

apoptosis; MDMA; neuroprotection; NPY; retina; toxicity

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; KETANSERIN; NEUROPEPTIDE Y; SEROTONIN 2A RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; DRUG MECHANISM; MACROGLIA; MICROGLIA; NECROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; RETINA NERVE CELL; TEMPERATURE DEPENDENCE;

ANIMALS; CELL DEATH; CELLS, CULTURED; HEAT; IMMUNOHISTOCHEMISTRY; KETANSERIN; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEURONS; NEUROPEPTIDE Y; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT2A; RETINA; SEROTONIN AGENTS; SEROTONIN ANTAGONISTS;

EID: 39649105016     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2007.12.027     Document Type: Article

References (68)

1. Álvaro A.R., Rosmaninho-Salgado J., Santiago A.R., Martins J., Aveleira C., Santos P.F., Pereira T., Gouveia D., Carvalho A.L., Grouzmann E., Ambrósio A.F., and Cavadas C. NPY in rat retina is present in neurons, in endothelial cells and also in microglial and Müller cells. Neurochem Int 50 (2007) 757-763
2. Azmitia E.C. Modern views on an ancient chemical: serotonin effects on cell proliferation, maturation, and apoptosis. Brain Res Bull 56 (2001) 413-424
3. Battaglia G., Fornai F., Busceti C.L., Aloisi G., Cerrito F., De Blasi A., Melchiorri D., and Nicoletti F. Selective blockade of mGlu5 metabotropic glutamate receptors is protective against methamphetamine neurotoxicity. J Neurosci 22 (2002) 2135-2141
4. Baumann M.H., Wang X., and Rothman R.B. 3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings. Psychopharmacology 189 (2007) 407-424 (Berl)
5. Broening H.W., Bowyer J.F., and Slikker Jr. W. Age-dependent sensitivity of rats to the long-term effects of the serotonergic neurotoxicant (+/-)-3,4-methylenedioxymethamphetamine (MDMA) correlates with the magnitude of the MDMA-induced thermal response. J Pharmacol Exp Ther 275 (1995) 325-333
6. Bruun A., Tornqvist K., and Ehinger B. Neuropeptide Y (NPY) immunoreactive neurons in the retina of different species. Histochemistry 86 (1986) 135-140
7. Cadet J.L., Krasnova I.N., Jayanthi S., and Lyles J. Neurotoxicity of substituted amphetamines: molecular and cellular mechanisms. Neurotox Res 11 (2007) 183-202
8. Capela J.P., Fernandes E., Remiao F., Bastos M.L., Meisel A., and Carvalho F. Ecstasy induces apoptosis via 5-HT(2A)-receptor stimulation in cortical neurons. Neurotoxicology 28 (2007) 868-875
9. Capela J.P., Ruscher K., Lautenschlager M., Freyer D., Dirnagl U., Gaio A.R., Bastos M.L., Meisel A., and Carvalho F. Ecstasy-induced cell death in cortical neuronal cultures is serotonin 2A-receptor-dependent and potentiated under hyperthermia. Neuroscience 139 (2006) 1069-1081
10. Carvalho M., Carvalho F., and Bastos M.L. Is hyperthermia the triggering factor for hepatotoxicity induced by 3,4-methylenedioxymethamphetamine (ecstasy)?. An in vitro study using freshly isolated mouse hepatocytes. Arch Toxicol 74 (2001) 789-793
11. Carvalho M., Carvalho F., Remiao F., de Lourdes Pereira M., Pires-das-Neves R., and de Lourdes Bastos M. Effect of 3,4-methylenedioxymethamphetamine ("ecstasy") on body temperature and liver antioxidant status in mice: influence of ambient temperature. Arch Toxicol 76 (2002) 166-172
12. Clauwaert K.M., Van Bocxlaer J.F., De Letter E.A., Van Calenbergh S., Lambert W.E., and De Leenheer A.P. Determination of the designer drugs 3,4-methylenedioxymethamphetamine, 3,4-methylenedioxyethylamphetamine, and 3,4-methylenedioxyamphetamine with HPLC and fluorescence detection in whole blood, serum, vitreous humor, and urine. Clin Chem 46 (2000) 1968-1977
13. Commins D.L., Vosmer G., Virus R.M., Woolverton W.L., Schuster C.R., and Seiden L.S. Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain. J Pharmacol Exp Ther 241 (1987) 338-345
14. Cunha-Oliveira T., Rego A.C., Cardoso S.M., Borges F., Swerdlow R.H., Macedo T., and de Oliveira C.R. Mitochondrial dysfunction and caspase activation in rat cortical neurons treated with cocaine or amphetamine. Brain Res 1089 (2006) 44-54
15. D'Angelo I., and Brecha N.C. Y2 receptor expression and inhibition of voltage-dependent Ca(2+) influx into rod bipolar cell terminals. Neuroscience 125 (2004) 1039-1049
16. De Letter E.A., Belpaire F.M., Clauwaert K.M., Lambert W.E., Van Bocxlaer J.F., and Piette M.H. Post-mortem redistribution of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") in the rabbit. Part II: post-mortem infusion in trachea or stomach. Int J Legal Med 116 (2002) 225-232
17. De Letter E.A., De Paepe P., Clauwaert K.M., Belpaire F.M., Lambert W.E., Van Bocxlaer J.F., and Piette M.H.A. Is vitreous humour useful for the interpretation of 3,4-methylenedioxymethamphetamine (MDMA) blood levels?. Int J Legal Med 114 (2000) 29-35
18. Domin H., Kajta M., and Smialowska M. Neuroprotective effects of MTEP, a selective mGluR5 antagonists and neuropeptide Y on the kainate-induced toxicity in primary neuronal cultures. Pharmacol Rep 58 (2006) 846-858
19. Farfel G.M., and Seiden L.S. Role of hypothermia in the mechanism of protection against serotonergic toxicity. II. Experiments with methamphetamine, p-chloroamphetamine, fenfluramine, dizocilpine and dextromethorphan. J Pharmacol Exp Ther 272 (1995) 868-875
20. Firth A.Y. Editorial: ocular effects of criminal drug use. Can J Ophthalmol 41 (2006) 140-146
21. Green A.R., Mechan A.O., Elliott J.M., O'Shea E., and Colado M.I. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol Rev 55 (2003) 463-508
22. Henry J.A. Ecstasy and the dance of death. BMJ 305 (1992) 5-6
23. Hutsler J.J., and Chalupa L.M. Development of neuropeptide Y immunoreactive amacrine and ganglion cells in the pre- and postnatal cat retina. J Comp Neurol 361 (1995) 152-164
24. Jacks A.S., and Hykin P.G. Retinal haemorrhage caused by "ecstasy.". Br J Ophthalmol 82 (1998) 842-843
25. Jen P.Y., Li W.W., and Yew D.T. Immunohistochemical localization of neuropeptide Y and somatostatin in human fetal retina. Neuroscience 60 (1994) 727-735
26. Jimenez A., Jorda E.G., Verdaguer E., Pubill D., Sureda F.X., Canudas A.M., Escubedo E., Camarasa J., Camins A., and Pallas M. Neurotoxicity of amphetamine derivatives is mediated by caspase pathway activation in rat cerebellar granule cells. Toxicol Appl Pharmacol 196 (2004) 223-234
27. Johnson M., Bush L.G., Hanson G.R., and Gibb J.W. Effects of ritanserin on the 3,4-methylenedioxymethamphetamine-induced decrease in striatal serotonin concentration and on the increase in striatal neurotensin and dynorphin A concentrations. Biochem Pharmacol 46 (1993) 770-772
28. Malberg J.E., Sabol K.E., and Seiden L.S. Co-administration of MDMA with drugs that protect against MDMA neurotoxicity produces different effects on body temperature in the rat. J Pharmacol Exp Ther 278 (1996) 258-267
29. Malberg J.E., and Seiden L.S. Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat. J Neurosci 18 (1998) 5086-5094
30. Meyer J.S., Grande M., Johnson K., and Ali S.F. Neurotoxic effects of MDMA ("ecstasy") administration to neonatal rats. Int J Dev Neurosci 22 (2004) 261-271
31. Michael J.C., Pak J., Pulido J., and de Venecia G. Central serous chorioretinopathy associated with administration of sympathomimetic agents. Am J Ophthalmol 136 (2003) 182-185
32. Michel M.C., Beck-Sickinger A., Cox H., Doods H.N., Herzog H., Larhammar D., Quirion R., Schwartz T., and Westfall T. XVI International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev 50 (1998) 143-150
33. Milhazes N., Cunha-Oliveira T., Martins P., Garrido J., Oliveira C., Rego A.C., and Borges F. Synthesis and cytotoxic profile of 3,4-methylenedioxymethamphetamine ("ecstasy") and its metabolites on undifferentiated PC12 cells: a putative structure-toxicity relationship. Chem Res Toxicol 19 (2006) 1294-1304
34. Miranda M., Bosch-Morell F., Johnsen-Soriano S., Barcia J., Almansa I., Asensio S., Araiz J., Messeguer A., and Romero F.J. Oxidative stress in rat retina and hippocampus after chronic MDMA ("ecstasy") administration. Neurochem Res 32 (2007) 1156-1162
35. Montiel-Duarte C., Varela-Rey M., Oses-Prieto J.A., Lopez-Zabalza M.J., Beitia G., Cenarruzabeitia E., and Iraburu M.J. 3,4-Methylenedioxymethamphetamine ("ecstasy") induces apoptosis of cultured rat liver cells. Biochim Biophys Acta 1588 (2002) 26-32
36. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65 (1983) 55-63
37. Oh S.J., D'Angelo I., Lee E.J., Chun M.H., and Brecha N.C. Distribution and synaptic connectivity of neuropeptide Y-immunoreactive amacrine cells in the rat retina. J Comp Neurol 446 (2002) 219-234
38. Orio L., O'Shea E., Sanchez V., Pradillo J.M., Escobedo I., Camarero J., Moro M.A., Green A.R., and Colado M.I. 3,4-Methylenedioxymethamphetamine increases interleukin-1beta levels and activates microglia in rat brain: studies on the relationship with acute hyperthermia and 5-HT depletion. J Neurochem 89 (2004) 1445-1453
39. Parrott A.C. Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or ecstasy. J Psychopharmacol 19 (2005) 71-83
40. Pootanakit K., Prior K.J., Hunter D.D., and Brunken W.J. 5-HT2a receptors in the rabbit retina: potential presynaptic modulators. Vis Neurosci 16 (1999) 221-230
41. Quinton M.S., and Yamamoto B.K. Causes and consequences of methamphetamine and MDMA toxicity. AAPS J 8 (2006) E337-E347
42. Reneman L., Endert E., de Bruin K., Lavalaye J., Feenstra M.G., de Wolff F.A., and Booij J. The acute and chronic effects of MDMA ("ecstasy") on cortical 5-HT2A receptors in rat and human brain. Neuropsychopharmacology 26 (2002) 387-396
43. Ricaurte G.A., DeLanney L.E., Wiener S.G., Irwin I., and Langston J.W. 5-Hydroxyindoleacetic acid in cerebrospinal fluid reflects serotonergic damage induced by 3,4-methylenedioxymethamphetamine in CNS of non-human primates. Brain Res 474 (1988) 359-363
44. Ricaurte G.A., Forno L.S., Wilson M.A., DeLanney L.E., Irwin I., Molliver M.E., and Langston J.W. (+/-)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates. JAMA 260 (1988) 51-55
45. Ricaurte G.A., Martello A.L., Katz J.L., and Martello M.B. Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations. J Pharmacol Exp Ther 261 (1992) 616-622
46. Ricaurte G.A., Yuan J., and McCann U.D. (+/-)3,4-Methylenedioxymethamphetamine ("ecstasy")-induced serotonin neurotoxicity: studies in animals. Neuropsychobiology 42 (2000) 5-10
47. Roth J., Rummel C., Barth S.W., Gerstberger R., and Hubschle T. Molecular aspects of fever and hyperthermia. Neurol Clin 24 (2006) 421-439 v.
48. Santiago A.R., Pereira T.S., Garrido M.J., Cristovao A.J., Santos P.F., and Ambrosio A.F. High glucose and diabetes increase the release of [3H]-d-aspartate in retinal cell cultures and in rat retinas. Neurochem Int 48 (2006) 453-458
49. Schmidt C.J. Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. J Pharmacol Exp Ther 240 (1987) 1-7
50. Schmidt C.J., Black C.K., and Taylor V.L. Antagonism of the neurotoxicity due to a single administration of methylenedioxymethamphetamine. Eur J Pharmacol 181 (1990) 59-70
51. Schmued L.C. Demonstration and localization of neuronal degeneration in the rat forebrain following a single exposure to MDMA. Brain Res 974 (2003) 127-133
52. Silva A.P., Carvalho A.P., Carvalho C.M., and Malva J.O. Functional interaction between neuropeptide Y receptors and modulation of calcium channels in the rat hippocampus. Neuropharmacology 44 (2003) 282-292
53. Silva A.P., Pinheiro P.S., Carvalho A.P., Carvalho C.M., Jakobsen B., Zimmer J., and Malva J.O. Activation of neuropeptide Y receptors is neuroprotective against excitotoxicity in organotypic hippocampal slice cultures. FASEB J 17 (2003) 1118-1120
54. Silva A.P., Cavadas C., and Grouzmann E. Neuropeptide Y and its receptors as potential therapeutic drug targets. Clin Chim Acta 326 (2002) 3-25
55. Silva A.P., Xapelli S., Grouzmann E., and Cavadas C. The putative neuroprotective role of neuropeptide Y in the central nervous system. Curr Drug Targets CNS Neurol Disord 4 (2005) 331-347
56. Silva A.P., Xapelli S., Pinheiro P.S., Ferreira R., Lourenco J., Cristovao A., Grouzmann E., Cavadas C., Oliveira C.R., and Malva J.O. Up-regulation of neuropeptide Y levels and modulation of glutamate release through neuropeptide Y receptors in the hippocampus of kainate-induced epileptic rats. J Neurochem 93 (2005) 163-170
57. Simantov R., and Tauber M. The abused drug MDMA (ecstasy) induces programmed death of human serotonergic cells. FASEB J 11 (1997) 141-146
58. Stone D.M., Stahl D.C., Hanson G.R., and Gibb J.W. The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain. Eur J Pharmacol 128 (1986) 41-48
59. Stumm G., Schlegel J., Schafer T., Wurz C., Mennel H.D., Krieg J.C., and Vedder H. Amphetamines induce apoptosis and regulation of bcl-x splice variants in neocortical neurons. FASEB J 13 (1999) 1065-1072
60. Tamburini I., Blandini F., Gesi M., Frenzilli G., Nigro M., Giusiani M., Paparelli A., and Fornai F. MDMA induces caspase-3 activation in the limbic system but not in striatum. Ann N Y Acad Sci 1074 (2006) 377-381
61. Thiriet N., Deng X., Solinas M., Ladenheim B., Curtis W., Goldberg S.R., Palmiter R.D., and Cadet J.L. Neuropeptide Y protects against methamphetamine-induced neuronal apoptosis in the mouse striatum. J Neurosci 25 (2005) 5273-5279
62. Wang X., Baumann M.H., Xu H., and Rothman R.B. 3,4-Methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein. Synapse 53 (2004) 240-248
63. Warren M.W., Zheng W., Kobeissy F.H., Cheng Liu M., Hayes R.L., Gold M.S., Larner S.F., and Wang K.K. Calpain- and caspase-mediated alphaII-spectrin and tau proteolysis in rat cerebrocortical neuronal cultures after ecstasy or methamphetamine exposure. Int J Neuropsychopharmacol (2006) 1-11
64. Warren M.W., Larner S.F., Kobeissy F.H., Brezing C.A., Jeung J.A., Hayes R.L., Gold M.S., and Wang K.K. Calpain and caspase proteolytic markers co-localize with rat cortical neurons after exposure to methamphetamine and MDMA. Acta Neuropathol 114 (2007) 277-286 (Berl)
65. Wettstein J.G., Earley B., and Junien J.L. Central nervous system pharmacology of neuropeptide Y. Pharmacol Ther 65 (1995) 397-414
66. Wu Y.F., and Li S.B. Neuropeptide Y expression in mouse hippocampus and its role in neuronal excitotoxicity. Acta Pharmacol Sin 26 (2005) 63-68
67. Xapelli S., Silva A.P., Ferreira R., and Malva J.O. Neuropeptide Y can rescue neurons from cell death following the application of an excitotoxic insult with kainate in rat organotypic hippocampal slice cultures. Peptides 28 (2007) 288-294
68. Xie T., Tong L., McLane M.W., Hatzidimitriou G., Yuan J., McCann U., and Ricaurte G. Loss of serotonin transporter protein after MDMA and other ring-substituted amphetamines. Neuropsychopharmacology 31 (2006) 2639-2651